6533b855fe1ef96bd12b1880
RESEARCH PRODUCT
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV
V CalvarusoMg BavettaD FerraroS GrimaudoE ConteRm PipitoneA CraxiV. Di Marcosubject
HCV HCC PEG IFN RBVyear | journal | country | edition | language |
---|---|---|---|---|
2012-01-01 |